A phase II study of KOS-862 (epothilone D) as second-line therapy in non-small cell lung cancer Meeting Abstract

  

Authors:	Rizvi, N.; Villalona-Calero, M.; Lynch, T.; Yee, L.; Gabrail, N.; Sandler, A.; Cropp, G.; Graham, M.; Palmer, G.
Abstract Title:	A phase II study of KOS-862 (epothilone D) as second-line therapy in non-small cell lung cancer
Meeting Title:	11th World Conference on Lung Cancer
Journal Title:	Lung Cancer
Volume:	49
Issue:	Suppl.2
Meeting Dates:	2005 Jul 3-6
Meeting Location:	Barcelona, Spain
ISSN:	0169-5002
Publisher:	Elsevier Ireland Ltd.
Date Published:	2005-07-01
Start Page:	S267
Language:	English
ACCESSION:	WOS:000231307802044
PROVIDER:	wos
DOI:	10.1016/S0169-5002(05)81058-X
Notes:	Meeting Abstract P-565 - 11th World Conference on Lung Cancer - JUL 03-06, 2005 - Barcelona, SPAIN - "Source: Wos"

https://synapse.mskcc.org/synapse/works/has_related_data_chk/44871